BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26339040)

  • 21. [Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2089-91. PubMed ID: 12484009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
    Idelevich E; Greif F; Mavor E; Miller R; Kashtan H; Susmalian S; Ariche A; Brenner B; Baruch NB; Dinerman M; Shani A
    Chemotherapy; 2009; 55(2):76-82. PubMed ID: 19077422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two cases of gastric cancer with multiple liver metastases responding to TS-1 with hepatic arterial infusion of CDDP following low-dose 5-FU and CDDP chemotherapy].
    Hirohashi Y; Sumi K; Matsuyama S
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):85-8. PubMed ID: 15675589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer].
    Shizawa R; Nagahori Y; Kumamoto N; Yamamoto H; Takeda K; Hamaguchi Y; Fukushima T; Yamamoto M; Mogaki M; Fukasawa S; Eguchi K; Kawahara M; Nagahori K; Hosoi H; Ohara T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2092-5. PubMed ID: 12484010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
    J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1627-30. PubMed ID: 14619480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Takahashi H; Nakano Y; Matsushita M; Ohzato H; Fukunaga M; Watanabe H; Kanoh Y; Yasue A; Okada K; Hata T; Iwazawa T; Matsui S; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1826-9. PubMed ID: 11086422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].
    Nashimoto A; Tsuchiya Y; Sasaki J; Sano M; Tanaka O; Tsutsui M; Makino H
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1402-5. PubMed ID: 9703839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of extrahepatic perfusion of anticancer drugs in the right gastric arterial region on fused images using combined CT/SPECT: is extrahepatic perfusion predictive of gastric toxicity?
    Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Morishita S; Takamori H; Chikamoto A; Kanemitsu K; Yamashita Y
    Cardiovasc Intervent Radiol; 2007; 30(3):392-7. PubMed ID: 17225975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of elderly advanced gastric cancer patient with multiple liver metastases effectively treated by hepatic arterial infusion chemotherapy].
    Minagawa R; Hasegawa H; Hamatsu T; Honboh T; Ushijima C; Ikebe M; Kitamura M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2484-6. PubMed ID: 21224614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
    Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.